ArticleHematology reports2026

Evaluation of mTOR, NFκB and BCL-2 Inhibitor Activity In Vitro in Karpas 1106P, a Primary Mediastinal B-Cell Lymphoma Cell Line.

Agata Majchrzak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.